Jaume Pons - 29 Dec 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
President & CEO, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
29 Dec 2022
Transactions value $
-$35,779
Form type
4
Filing time
03 Jan 2023, 19:29:46
Previous filing
09 Aug 2022
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Sale -$35.8K -3.23K -0.6% $11.07 540K 29 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.